
Experimental mRNA therapy promotes repair after heart attack damage
Scientists have developed a treatment that ‘reawakens’ heart muscle cells so they start to divide and help repair damaged muscle.

Scientists have developed a treatment that ‘reawakens’ heart muscle cells so they start to divide and help repair damaged muscle.

In a new CRISPR experiment, a single infusion of a gene-editing treatment kept triglyceride levels low in monkeys for three years.

Researchers have successfully prevented the development of severe heart failure in a mouse model of heart attack by blocking a protein that triggers the formation of excessive scar tissue.

Tandem Diabetes Care has announced receipt of Health Canada approval of a license amendment for the t:slim X2 insulin pump with Control-IQ+ automated insulin delivery technology.

Tandem Diabetes Care (Nasdaq: TNDM) has secured an FDA clearance for a tubeless version of its miniaturized automated insulin delivery system.

Developed in collaboration with Avicenna.AI, the newly FDA-cleared technology introduces UPTUNITY™, Bracco’s new portfolio of AI-enabled clinical decision support solutions.

A research team led by Dr. Hyun-Soo Cho at the Korea Research Institute of Bioscience and Biotechnology (KRIBB), in collaboration with Professor Keun Hur’s team at Kyungpook National University, has identified how miR-1290, a type of microRNA transferred from fibroblasts surrounding tumors, promotes the growth of triple-negative breast cancer cells.

A combination approach successfully overcame treatment resistance and led to durable responses in preclinical models of advanced breast cancer.

On an organ-on-a-chip, researchers can now explore how tumors grow and interact with their surroundings.

UVA Comprehensive Cancer Center researchers have found an answer to one of the great mysteries of human biology, and the discovery could have major implications for the battle against breast cancer and other diseases.